Market cap: $2,643,287,297
Exchange: NAS
Sector: Health Technology
Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands.
Company Name
Merus N.V
Average Volume (10 days)
828,801
Average Volume (30 days)
605,368
Moving Average (50 days)
$43.74
Moving Average (200 days)
$33.85
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
2,643,287,297
Shares Outstanding
58,687,551
52-Week High Split Adjust Only
52.04
52-Week Low Split Adjust Only
18.21
Employee Count
202
Beta
1.6714
Next Earnings Date
2024-05-02
TTM Dividend Rate Per Share
0
Past 5 days
0.13%
Past 30 days
0%
Past 3 months
0.32%
Past 6 months
1.2%
Past year
1.27%
Past 2 years
1.1%
Past 5 years
1.77%
Max % Change
3.49%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Merus N.V | MRUS | n/a | n/a | -9.9 | n/a | n/a |
| Peer Avg | N/A | n/a | n/a | -13.3 | n/a | n/a |
| Ocular Therapeutix Inc | OCUL | n/a | n/a | -19.1 | n/a | n/a |
| Olema Pharmaceuticals Inc | OLMA | n/a | n/a | -21.2 | n/a | n/a |
| Oncocyte Corporation | OCX | n/a | n/a | -13.1 | n/a | n/a |
| Oragenics Inc. | OGEN | n/a | n/a | n/a | n/a | n/a |